Association of cystic fibrosis transmembrane conductance regulator gene variants with acute lung injury in African American children with pneumonia

Critical Care Medicine

Volumn 40, Issue 11, 2012, Pages 3042-3049

  Baughn, Julie M ^a   Quasney, Michael W ^b,d   Simpson, Pippa ^c,d   Merchant, Daniel ^b,d   Li, Shun Hwa ^c,d   Levy, Hara ^a,d   Dahmer, Mary K ^b,d  

^a Section of Pulmonary and Sleep Medicine   (United States)

^b Section of Critical Care Medicine   (United States)

^c Department of Pediatrics   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

acute lung injury; acute respiratory distress syndrome; genetic association study; pediatrics; pneumonia

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ACUTE LUNG INJURY; ADOLESCENT; AFRICAN AMERICAN; ALLELE; ARTICLE; ARTIFICIAL VENTILATION; CAUCASIAN; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; DISEASE ASSOCIATION; DNA POLYMORPHISM; EMERGENCY WARD; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SICKLE CELL ANEMIA; TERTIARY HEALTH CARE;

ACUTE LUNG INJURY; ADOLESCENT; AFRICAN AMERICANS; ALLELES; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA PRIMERS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PNEUMONIA; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES;

EID: 84868209535     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31825d8f73     Document Type: Article

References (59)

1. McIntosh K: Community-acquired pneumonia in children. N Engl J Med 2002; 346:429-437
2. Lee GE, Lorch SA, Sheffler-Collins S, et al: National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics 2010; 126:204-213
3. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349
4. Matthay MA: Alveolar fluid clearance in patients with ARDS: Does it make a difference? Chest 2002; 122:340S-343S
5. Matthay MA, Robriquet L, Fang X: Alveolar epithelium: Role in lung fluid balance and acute lung injury. Proc Am Thorac Soc 2005; 2:206-213
6. Fang X, Fukuda N, Barbry P, et al: Novel role for CFTR in fluid absorption from the distal airspaces of the lung. J Gen Physiol 2002; 119:199-207
7. Fang X, Song Y, Hirsch J, et al: Contribution of CFTR to apical-basolateral fluid transport in cultured human alveolar epithelial type II cells. Am J Physiol Lung Cell Mol Physiol 2006; 290:L242-L249
8. Regnier A, Dannhoffer L, Blouquit-Laye S, et al: Expression of cystic fibrosis transmembrane conductance regulator in the human distal lung. Hum Pathol 2008; 39:368-376
9. Nagel G, Szellas T, Riordan JR, et al: Nonspecific activation of the epithelial sodium channel by the CFTR chloride channel. EMBO Rep 2001; 2:249-254
10. Reddy MM, Light MJ, Quinton PM: Activation of the epithelial Na+ channel (ENaC) requires CFTR Cl-channel function. Nature 1999; 402:301-304
11. Bremer S, Hoof T, Wilke M, et al: Quantitative expression patterns of multidrug-resistance P-glycoprotein (MDR1) and differentially spliced cystic-fibrosis transmembraneconductance regulator mRNA transcripts in human epithelia. Eur J Biochem 1992; 206:137-149
12. Davis PB: Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006; 173:475-482
13. Hunter MJ, Treharne KJ, Winter AK, et al: Expression of wild-type CFTR suppresses NF-kappaB-driven inflammatory signalling. PLoS One 2010; 5:e11598
14. Tirouvanziam R, de Bentzmann S, Hubeau C, et al: Inflammation and infection in naive human cystic fibrosis airway grafts. Am J Respir Cell Mol Biol 2000; 23:121-127
15. Vandivier RW, Richens TR, Horstmann SA, et al: Dysfunctional cystic fibrosis transmembrane conductance regulator inhibits phagocytosis of apoptotic cells with proinflammatory consequences. Am J Physiol Lung Cell Mol Physiol 2009; 297:L677-L686
16. Vij N, Mazur S, Zeitlin PL: CFTR is a negative regulator of NFkappaB mediated innate immune response. PLoS One 2009; 4:e4664
17. Weber AJ, Soong G, Bryan R, et al: Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Clchannel function. Am J Physiol Lung Cell Mol Physiol 2001; 281:L71-L78
18. Mueller C, Braag SA, Keeler A, et al: Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses. Am J Respir Cell Mol Biol 2011; 44:922-929
19. Su X, Looney MR, Su HE, et al: Role of CFTR expressed by neutrophils in modulating acute lung inflammation and injury in mice. Inflamm Res 2011; 60:619-632
20. Strong TV, Wilkinson DJ, Mansoura MK, et al: Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMPactivated chloride conductance. Hum Mol Genet 1993; 2:225-230
21. Pissarra LS, Farinha CM, Xu Z, et al: Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation. Chem Biol 2008; 15:62-69
22. Chu CS, Trapnell BC, Curristin S, et al: Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 1993; 3:151-156
23. Chu CS, Trapnell BC, Murtagh JJ Jr, et al: Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium. EMBO J 1991; 10:1355-1363
24. Cuppens H, Lin W, Jaspers M, et al: Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest 1998; 101:487-496
25. Pagani F, Buratti E, Stuani C, et al: Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9. J Biol Chem 2003; 278:26580-26588
26. Niksic M, Romano M, Buratti E, et al: Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9. Hum Mol Genet 1999; 8:2339-2349
27. Buratti E, Baralle FE: Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem 2001; 276:36337-36343
28. Dujardin G, Buratti E, Charlet-Berguerand N, et al: CELF proteins regulate CFTR premRNA splicing: Essential role of the divergent domain of ETR-3. Nucleic Acids Res 2010; 38:7273-7285
29. Delaney SJ, Rich DP, Thomson SA, et al: Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels. Nat Genet 1993; 4:426-431
30. Gregory RJ, Rich DP, Cheng SH, et al: Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol Cell Biol 1991; 11:3886-3893
31. Chu CS, Trapnell BC, Curristin SM, et al: Extensive posttranscriptional deletion of the coding sequences for part of nucleotidebinding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. J Clin Invest 1992; 90:785-790
32. de Meeus A, Guittard C, Desgeorges M, et al: Linkage disequilibrium between the M470V variant and the IVS8 polyT alleles of the CFTR gene in CBAVD. J Med Genet 1998; 35:594-596
33. Mai HN, Hijikata M, Inoue Y, et al: Pulmonary Mycobacterium avium complex infection associated with the IVS8-T5 allele of the CFTR gene. Int J Tuberc Lung Dis 2007; 11:808-813
34. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149(3 Pt 1): 818-824
35. Dahmer MK, O'Cain P, Patwari PP, et al: The influence of genetic variation in surfactant protein B on severe lung injury in African American children. Crit Care Med 2011; 39:1138-1144
36. Patwari PP, O'Cain P, Goodman DM, et al: Interleukin-1 receptor antagonist intron 2 variable number of tandem repeats polymorphism and respiratory failure in children with community-acquired pneumonia. Pediatr Crit Care Med 2008; 9:553-559
37. Russell R, Quasney MW, Halligan N, et al: Genetic variation in MYLK and lung injury in children and adults with communityacquired pneumonia. Pediatr Crit Care Med 2010; 11:731-736
38. Beaty TH, Fallin MD, Hetmanski JB, et al: Haplotype diversity in 11 candidate genes across four populations. Genetics 2005; 171:259-267
39. Goddard KA, Hopkins PJ, Hall JM, et al: Linkage disequilibrium and allele-frequency distributions for 114 single-nucleotide polymorphisms in five populations. Am J Hum Genet 2000; 66:216-234
40. Balding DJ: A tutorial on statistical methods for population association studies. Nat Rev Genet 2006; 7:781-791
41. Gauderman WJ: Sample size requirements for matched case-control studies of geneenvironment interaction. Stat Med 2002; 21:35-50
42. Gauderman WJ, Morrison JM. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies, 2006. Available at: http://hydra.usc.edu/gxe. Accessed April 1, 2009
43. Chill? M, Casals T, Mercier B, et al: Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995; 332:1475-1480
44. Stephens M, Donnelly P: A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73:1162-1169
45. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989
46. Zaykin DV, Pudovkin A, Weir BS: Correlationbased inference for linkage disequilibrium with multiple alleles. Genetics 2008; 180:533-545
47. SeattleSNPs. Available at: http://pga. gs.washington.edu/. Accessed April 1, 2009
48. Groman JD, Hefferon TW, Casals T, et al: Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. Am J Hum Genet 2004; 74:176-179
49. Kiesewetter S, Macek M Jr, Davis C, et al: A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet 1993; 5:274-278
50. Hefferon TW, Broackes-Carter FC, Harris A, et al: Atypical 5' splice sites cause CFTR exon 9 to be vulnerable to skipping. Am J Hum Genet 2002; 71:294-303
51. Pagani F, Buratti E, Stuani C, et al: Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. J Biol Chem 2000; 275:21041-21047
52. Zuccato E, Buratti E, Stuani C, et al: An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing. J Biol Chem 2004; 279:16980-16988
53. Ayala YM, Pagani F, Baralle FE: TDP43 depletion rescues aberrant CFTR exon 9 skipping. FEBS Lett 2006; 580:1339-1344
54. Buratti E, D?k T, Zuccato E, et al: Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 2001; 20:1774-1784
55. Maria Ciminelli B, Bombieri C, Ciccacci C, et al: Anthropological features of the CFTR gene: Its variability in an African population. Ann Hum Biol 2011; 38:203-209
56. Monaghan KG, Jackson CE, KuKuruga DL, et al: Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol-related pancreatitis. Am J Med Genet 2000; 94:120-124
57. Kerem B, Rommens JM, Buchanan JA, et al: Identification of the cystic fibrosis gene: Genetic analysis. Science 1989; 245:1073-1080
58. Cystic Fibrosis Mutation Database. Available at: http://www.genet. sickkids.on.ca/Home. html. Accessed February 1, 2009
59. Chanock SJ, Manolio T, Boehnke M, et al: NCI-NHGRI Working Group on Replication in Association Studies: Replicating genotypephenotype associations. Nature 2007; 447:655-660